Little Thief: The Domestic Ferret
Download in electronic PDF format for $75
Abstract: Three illnesses appear commonly in pet ferrets: cardiomyopathies, insulinoma, and adrenal associated endocrinopathy. Treatment for dilated cardiomyopathy include ACE inhibitors, and furosemide is recommended for the treatment for long-term diuresis treatment of congestive heart failure. Insulinoma, cancer of the pancreas, is the most common neoplasm of the American ferret, oftentimes treated by surgically excising the cancerous lobes, optionally can be treated with steroids that suppress insulin. Adrenal disease in ferrets is due to excessive release of estrogen from a proliferative adrenal lesion and theoretically is associated with the light cycle or photoperiod to which a ferret is exposed. Adrenal disease is commonly treated with environmental changes; melatonin, administered orally or by implant; investigative hormone implant treatments to decrease estrogen levels; and antihistamines to decrease episodic itching. This article provides the history of ferrets, clinical and medical evaluations, common disea
Related Keywords:
Rita L. Benischek, DPh, MA, ferrets, veterinary pharmacy, cardiomyopathy, insulinoma, adrenal-assocated endocrinopathy, formulations, enrofloxacin, melatonin
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Little Thief: The Domestic Ferret
Benischek Rita L
|
Sep/Oct 2009
Pg. 362-365
|
Veterinary Transdermal Medications: A to Z
Davidson Gigi S
|
Mar/Apr 2003
Pg. 106-113
|
Veterinary Compounding for Ferrets
Miller Cari E
|
Mar/Apr 2002
Pg. 136-139
|
Congestive Heart Failure and Other Medical Facts About Ferrets; Scout's Story: A Case Report on Treating Congestive Heart Failure in a Ferret
Williams LaVonn A, Riley Kari
|
Sep/Oct 2009
Pg. 367-371
|
Adrenal Fatigue
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 39-44
|
Restructuring the Art of Health by Pharmacists: Formulation Designs with Oral Vehicles--Teaching Pharmacy Students
Benischek Rita
|
Mar/Apr 2017
Pg. 105-108
|
Enrofloxacin 11.35 mg/mL in Ora-Blend, Veterinary
Allen Loyd V Jr
|
Nov/Dec 2022
Pg. 511
|
Navigating New Territories in Compounding for Veterinary Medicine
Davidson Gigi S
|
Sep/Oct 2002
Pg. 324-327
|
Evaluating Transdermals Medication Froms for Veterinary Patients, Part 2
Davidson Gigi S
|
May/Jun 2001
Pg. 214-215
|
A Compendium of Compounding Agents and Formulations, Part 1: Melatonin
Riepl Mike
|
Jan/Feb 2022
Pg. 18-23
|
Art of Pharmacy v. State
Standridge Rob
|
May/Jun 2022
Pg. 182-186
|
The Current Landscape of Veterinary Compounding in the Pharmacy Setting
Gochenauer Alexandria E, Holmes Erin R, Barber Katie E, Forsythe Lauren R
|
Sep/Oct 2019
Pg. 422-427
|
Taurine for the Treatment of Canine Dilated Cardiomyopathy
Vail Jane
|
Nov/Dec 2006
Pg. 421-424
|
Enrofloxacin 0.5%, Ketoconazole 0.1%, and Triamcinolone Acetonide 0.1% Otic Gel
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 507
|
Case Report: Treatment of Canine Colitis in a Dachshund with a Compounded Oral Tri-Mix (Green Lizard)
Benischek Rita L, Riffell Gregory S, Mauldin Todd
|
Nov/Dec 2006
Pg. 426-427
|
How To Perform a Study in Your Pharmacy with Little or No Effort
Reed-Kane Dana
|
May/Jun 2002
Pg. 186-187
|
BioBullet: Innovative Pharmaceutical Compounding for Treating Cattle
Benischek Rita L
|
Nov/Dec 2006
Pg. 428-433
|
The Current Landscape of Veterinary Compounding in the Veterinary Setting
Gochenauer Alexandria E, Rishniw Mark, Holmes Erin R, Forsythe Lauren R
|
Sep/Oct 2019
Pg. 428-433
|
Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies
Pritchett Jon, McCrory Gary, Kraemer Cheri, Jensen Brenda, Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 7-16
|
Summertime in an American Apothecary Garden
Benischek Rita
|
Jan/Feb 2009
Pg. 38-41
|
Return to Top |